Explaining the relationship between race/ethnicity and pharmacy purchased syringes among injection drug users in New York City

被引:0
作者
Fuller, CM
Galea, S
Blaney, S
Ompad, DC
Deren, S
des Jarlais, D
Vlahov, D
机构
[1] Columbia Univ, Ctr Infect Dis Epidemiol Res, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY 10032 USA
[2] New York Acad Med, Ctr Urban Epidemiol Studies, New York, NY USA
[3] Natl Dev & Res Inst Inc, New York, NY USA
[4] Beth Israel Deaconess Med Ctr, Baron Edmond de Rothschild Chem Dependency Inst, New York, NY USA
关键词
HIV; injection drug use; pharmacy; racial disparities;
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objective: Pharmacy syringe sales without a prescription became legal in New York State on January 1, 2001 through the Expanded Syringe Access Demonstration Program (ESAP). At the same time, Pharmacy use among Black and Hispanic injection drug users was found to be significantly lower when compared to Whites. The purpose of this study was to assess the factors that could explain the relationship between race/ethnicity and pharmacy use. Design: Data were combined from 2 on-going injection drug user (IDU) studies in 2 New York City neighborhoods. Social and behavioral factors independently associated with ever purchasing a nonprescription syringe in the past 6 months and examined using cross-sectional logistic regression. Results: Of 33 7 IDUs, the majority were male (79%), Hispanic (73%) and had a mean age of 35 years. In bivariate analysis, IDUs who reported pharmacy use were less likely to be Black or Hispanic, older, and to have reported recent syringe exchange program (SEP) attendance compared to non-pharmacy users. Additionally, pharmacy users were more likely to have knowledge of ESAP, and report discrimination by police in the past year compared to non-users. After adjustment for recent SEP attendance (adjusted odds ratio [AOR]=0.27; 95% confidence interval [CI]=0.14-0.55), ESAP knowledge (AOR=13.11; 95% CI=6.54-26.31), discrimination by police (AOR=3.56; 95% CI=1.73-7.35), and discrimination due to race (AOR=0.25, 95% CI=0.11-0.58), race/ethnicity was not a Significant predictor of pharmacy use. Conclusions: Race/ethnicity may not be an important determinant of ESAP when more salient social circumstances, such as past discrimination, are considered. Educational efforts should be enhanced to reach those who continue to perceive barriers to ESAP.
引用
收藏
页码:589 / 596
页数:8
相关论文
共 50 条
  • [21] CD4 LYMPHOCYTOPENIA AMONG INJECTING DRUG-USERS IN NEW-YORK-CITY
    JARLAIS, DCD
    FRIEDMAN, SR
    MARMOR, M
    MILDVAN, D
    YANCOVITZ, S
    SOTHERAN, JL
    WENSTON, J
    BEATRICE, S
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1993, 6 (07): : 820 - 822
  • [22] Dual HIV Risk: Receptive Syringe Sharing and Unprotected Sex Among HIV-Negative Injection Drug Users in New York City
    Alan Neaigus
    Kathleen H. Reilly
    Samuel M. Jenness
    Holly Hagan
    Travis Wendel
    Camila Gelpi-Acosta
    AIDS and Behavior, 2013, 17 : 2501 - 2509
  • [23] Dual HIV Risk: Receptive Syringe Sharing and Unprotected Sex Among HIV-Negative Injection Drug Users in New York City
    Neaigus, Alan
    Reilly, Kathleen H.
    Jenness, Samuel M.
    Hagan, Holly
    Wendel, Travis
    Gelpi-Acosta, Camila
    AIDS AND BEHAVIOR, 2013, 17 (07) : 2501 - 2509
  • [24] Differences in Self-Reported Discrimination by Primary Type of Drug Used among New York City Drug Users
    Crawford, Natalie D.
    Rudolph, Abby E.
    Jones, Kandice
    Fuller, Crystal
    AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE, 2012, 38 (06) : 588 - 592
  • [25] What happened to the HIV epidemic among non-injecting drug users in New York City?
    Des Jarlais, Don C.
    Arasteh, Kamyar
    McKnight, Courtney
    Feelemyer, Jonathan
    Campbell, Aimee N. C.
    Tross, Susan
    Cooper, Hannah L. F.
    Hagan, Holly
    Perlman, David C.
    ADDICTION, 2017, 112 (02) : 290 - 298
  • [26] Gender differences in sexual behaviors, sexual partnerships, and HIV among drug users in New York City
    Absalon, Judith
    Fuller, Crystal M.
    Ompad, Danielle C.
    Blaney, Shannon
    Koblin, Beryl
    Galea, Sandro
    Vlahov, David
    AIDS AND BEHAVIOR, 2006, 10 (06) : 707 - 715
  • [27] Putting risk compensation to rest: reframing the relationship between risk behavior and antiretroviral therapy among injection drug users
    Marshall, Brandon D. L.
    Wood, Evan
    AIDS, 2012, 26 (18) : 2405 - 2407
  • [28] The Relationship between Drug User Stigma and Depression among Inner-City Drug Users in Baltimore, MD
    Latkin, Carl
    Davey-Rothwell, Melissa
    Yang, Jing-yan
    Crawford, Natalie
    JOURNAL OF URBAN HEALTH-BULLETIN OF THE NEW YORK ACADEMY OF MEDICINE, 2013, 90 (01): : 147 - 156
  • [29] HIV Among Drug Users at Beth Israel Medical Center, New York City, the First 25 Years
    Des Jarlais, Don C.
    Arasteh, Kamyar
    Friedman, Samuel R.
    SUBSTANCE USE & MISUSE, 2011, 46 (2-3) : 131 - 139
  • [30] Receptive syringe sharing among injection drug users in Harlem and the Bronx during the New York state expanded syringe access demonstration program
    Pouget, ER
    Deren, SY
    Fuller, CM
    Blaney, S
    McMahon, JM
    Kang, SY
    Tortu, S
    Andia, JE
    Des Jarlais, DC
    Vlahov, D
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2005, 39 (04) : 471 - 477